Literature DB >> 10355116

Selection of vaginal H2O2-generating Lactobacillus species for probiotic use.

V S Ocaña1, A A Pesce de Ruiz Holgado, M E Nader-Macías.   

Abstract

Lactobacilli are believed to contribute to the control of the vaginal microflora by different mechanisms such as production of antagonistic substances like lactic acid, bacteriocins, and H2O2. This paper describes the selection of H2O2-generating lactobacilli among 35 hydrophobic isolates from the human vagina. Lactobacillus crispatus F117, which generated the highest H2O2 level, was chosen to study: (a) the kinetics of H2O2 production considering different culture conditions, and (b) the effect of this metabolite on the growth of urogenital tract pathogens. The levels of H2O2 in L. crispatus supernatant increased during its growth and were maximum at the early stationary phase (3.29 mmol H2O2 L-1) under aerated conditions (agitated cultures). In nonagitated cultures there were no detectable levels of H2O2. L. crispatus F117 spent supernatant inhibited Staphylococcus aureus growth in plaque assay. Inhibition was due to H2O2 since catalase treatment of the supernatant suppressed inhibition. In mixed cultures performed with L. crispatus and S. aureus a significant decrease in pathogen growth was observed. The inhibitory effect depended on the initial inoculum of S. aureus. Further evaluation of the properties of L. crispatus F117 will be performed to consider its inclusion in a probiotic for local use in the vaginal tract.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10355116     DOI: 10.1007/pl00006802

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  26 in total

1.  Probiotic Therapy and Functional Foods for Prevention of Urinary Tract Infections: State of the Art and Science.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-12       Impact factor: 3.725

2.  Lactococcus lactis SpOx spontaneous mutants: a family of oxidative-stress-resistant dairy strains.

Authors:  Tatiana Rochat; Jean-Jacques Gratadoux; Gérard Corthier; Bérard Coqueran; Maria-Elena Nader-Macias; Alexandra Gruss; Philippe Langella
Journal:  Appl Environ Microbiol       Date:  2005-05       Impact factor: 4.792

3.  Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection.

Authors:  Ann E Stapleton; Melissa Au-Yeung; Thomas M Hooton; David N Fredricks; Pacita L Roberts; Christopher A Czaja; Yuliya Yarova-Yarovaya; Tina Fiedler; Marsha Cox; Walter E Stamm
Journal:  Clin Infect Dis       Date:  2011-04-14       Impact factor: 9.079

4.  Characterization of a bacteriocin-like substance produced by a vaginal Lactobacillus salivarius strain.

Authors:  V S Ocaña; A A Pesce De Ruiz Holgado; M E Nader-Macías
Journal:  Appl Environ Microbiol       Date:  1999-12       Impact factor: 4.792

5.  Comparative genome analyses of Lactobacillus crispatus isolated from different ecological niches reveal an environmental adaptation of this species to the human vaginal environment.

Authors:  Leonardo Mancabelli; Walter Mancino; Gabriele Andrea Lugli; Christian Milani; Alice Viappiani; Rosaria Anzalone; Giulia Longhi; Douwe van Sinderen; Marco Ventura; Francesca Turroni
Journal:  Appl Environ Microbiol       Date:  2021-02-12       Impact factor: 4.792

6.  Evaluation of in vitro Probiotic Potential of Pediococcus pentosaceus OZF Isolated from Human Breast Milk.

Authors:  Ozlem Osmanagaoglu; Fadime Kiran; Haluk Ataoglu
Journal:  Probiotics Antimicrob Proteins       Date:  2010-10       Impact factor: 4.609

Review 7.  Potential uses of probiotics in clinical practice.

Authors:  Gregor Reid; Jana Jass; M Tom Sebulsky; John K McCormick
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

8.  Oral administration of Lactobacillus strains isolated from breast milk as an alternative for the treatment of infectious mastitis during lactation.

Authors:  E Jiménez; L Fernández; A Maldonado; R Martín; M Olivares; J Xaus; J M Rodríguez
Journal:  Appl Environ Microbiol       Date:  2008-06-06       Impact factor: 4.792

9.  Streptococcal antagonism in oral biofilms: Streptococcus sanguinis and Streptococcus gordonii interference with Streptococcus mutans.

Authors:  Jens Kreth; Yongshu Zhang; Mark C Herzberg
Journal:  J Bacteriol       Date:  2008-04-25       Impact factor: 3.490

10.  Effects of Antimicrobial Peptide GH12 on the Cariogenic Properties and Composition of a Cariogenic Multispecies Biofilm.

Authors:  Wentao Jiang; Yufei Wang; Junyuan Luo; Xinwei Li; Xuedong Zhou; Wei Li; Linglin Zhang
Journal:  Appl Environ Microbiol       Date:  2018-11-30       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.